Reduced expression of the Indy (I'm Not Dead, Yet) gene in D. melanogaster and its homolog in C. elegans prolongs life span and in D. melanogaster augments mitochondrial biogenesis in a manner akin to caloric restriction. However, the cellular mechanism by which Indy does this is unknown. Here, we report on the knockout mouse model of the mammalian Indy (mIndy) homolog, SLC13A5. Deletion of mIndy in mice (mINDY À/À mice) reduces hepatocellular ATP/ADP ratio, activates hepatic AMPK, induces PGC-1a, inhibits ACC-2, and reduces SREBP-1c levels. This signaling network promotes hepatic mitochondrial biogenesis, lipid oxidation, and energy expenditure and attenuates hepatic de novo lipogenesis. Together, these traits protect mINDY À/À mice from the adiposity and insulin resistance that evolve with high-fat feeding and aging. Our studies demonstrate a profound effect of mIndy on mammalian energy metabolism and suggest that mINDY might be a therapeutic target for the treatment of obesity and type 2 diabetes.
INTRODUCTION
Energy balance and insulin action are both closely related to life span. Whereas caloric excess leads to obesity, insulin resistance, and increased mortality, caloric restriction reduces adiposity and increases lipid oxidation, insulin sensitivity, and mitochondrial biogenesis. In addition, caloric restriction reverses obesity and type 2 diabetes, delays aging, and prolongs life in many species, including primates (Hursting et al., 2003; Lopez-Lluch et al., 2006; Hunt et al., 2006; Fontana and Klein, 2007; Colman et al., 2009 ). Mediators of the beneficial effects of caloric restriction include decreased plasma concentrations of anabolic hormones and growth factors, i.e., insulin and insulin-like growth factors (Fontana and Klein, 2007) . Reduced expression of the Indy (for I'm Not Dead, Yet) gene in D. melanogaster and its homolog in C. elegans has been shown to promote longevity in a manner akin to caloric restriction; however, the cellular mechanism by which reduced expression of Indy leads to increased survival is unknown (Rogina et al., 2000; Fei et al., 2003 Fei et al., , 2004 Wang et al., 2009) .
In D. melanogaster, Indy encodes a nonelectrogenic dicarboxylate and citrate transporter (Knauf et al., 2002 (Knauf et al., , 2006 , and it is mainly expressed in the fat body, midgut, and oenocyte (Rogina et al., 2000) , thus, in the major organs of intermediary metabolism in flies. In mammals, the gene product of SLC13A5, the sodium-coupled citrate transporter NaCT (mINDY), shares the highest sequence and functional similarity with D. melanogaster INDY (Inoue et al., 2002a) , and it is predominantly expressed in liver cells (Inoue et al., 2002b; Gopal et al., 2007) .
In order to examine the effect that INDY might have on energy metabolism and insulin sensitivity in mammals, we created a knockout mouse model (mINDY À/À mice) of the mammalian Indy homolog SLC13A5 (mIndy) and assessed the effect of mIndy deletion on energy homeostasis and energy storage in vivo. Furthermore, we assessed the impact of mIndy deletion on insulin action in young, chow-fed mice, as well as after exposing them to two perturbations known to induce insulin resistance, specifically, high-fat feeding and aging.
RESULTS
Transport Kinetics of mINDY cDNA encoding mINDY was cloned and stably transfected into HEK293 cells. The uptake capacities of mINDY for the two substrates with the highest plasma concentrations, namely citrate and succinate, were analyzed. mINDY is a high-capacity transporter for citrate at physiological concentrations (K m = 49 ± 9 mM, V max = 3760 ± 160 [pmol/(mg x min)]) ( Figure 1A ), and it transports succinate with an intermediate capacity (K m = 105 ± 9 mM, V max = 443 ± 20 [pmol/(mg 3 min)]) ( Figure 1B ).
Generation of mINDY -/-Mice mINDY À/À mice were generated as described in Figures S1A-S1E (available online). We performed Southern blot analysis for FloxP detection under stringent hybridization and washing (A and B) mINDY transport kinetics for citrate (A) and succinate (B). HEK293 cells were transfected with the plasmids pIndy-mouse.3.1 or empty expression vector pcDNA3.1(+). Uptake assays were performed in HEK-mIndy cells and HEK-Co/418 cells transfected with the empty expression vector pcDNA3.1(+) serving as control cells. Net uptake is expressed as the difference between the uptake of substrates into HEK-mIndy cells and HEK-Co/418 cells (n = 3-6 for each concentration). K m values were determined by fitting the data to a nonlinear regression curve fit. (C) mIndy mRNA tissue expression in mINDY +/+ and mINDY À/À mice (n = 3-4).
conditions. The results shown in Figure S1E clearly indicate that the digests obtained with BamH1 gave one single band for wildtype and KO/+ genomic DNA samples (3.5 kb), while the FloxP/+ genomic DNA samples showed the 3.5 kb band and a specific band of 1.76 kb which correspond to the FloxP construction. The litters produced when heterozygous (KO/+) mINDY mice (mINDY +/À ) were bred contained the expected ratio of mIndy wild-type (mINDY +/+ ), mINDY +/À mice, and homozygous mIndy (mINDY À/À ) pups, indicating no substantial embryonic lethality. In wild-type mice, Indy mRNA expression was highest in liver and low in white adipose tissue, brown adipose tissue, skeletal muscle, small intestines, and the pancreas ( Figure 1C ), confirming previous mIndy expression levels in rodents (Gopal et al., 2007) and humans (Nishimura and Naito, 2008 Expression of SLC13A3, encoding another hepatic plasma membrane tri-/dicarboxylate transporter, was increased $3-fold in the liver of regular chow-fed mINDY À/À mice, probably compensating for mIndy loss. This compensatory increase was completely abolished when mice were fed a HFD ( Figure S2 ). mIndy expression did not change significantly with high-fat feeding or aging in mice (data not shown). In accordance with reduced cellular citrate uptake, GC/MS plasma metabolite analysis revealed increased relative plasma citrate concentrations in the mINDY À/À mice, a trend for increased malate concentrations, and no changes in succinate and fumarate concentrations ( Figure 1E ).
Body Weight and Energy Expenditure
Compared to mINDY +/+ mice, body weights of mINDY +/À and mINDY À/À mice on a regular chow were 2% and 10% lower, respectively, at 4 weeks of age ( Figure 2A ). mINDY À/À mice showed an increasing difference in body weight compared to mINDY +/+ mice with time ( Figures 2A and 2B ). The relative percentage of lean body mass and fat mass, as assessed by 1 H-MRS, did not differ between genotypes up to an age of 3 months ( Figure S3A ). Body length of mINDY +/À and mINDY À/À mice at 3 months of age was 9.9 ± 0.2 cm and 9.9 ± 0.1 cm, respectively, and 10.2 ± 0.1 cm in mINDY +/+ mice ( Figure S3B ).
Thus, loss of mIndy reduced overall growth. To determine the reasons, mice were studied in metabolic cages. Oxygen consumption (V O2 ), carbon dioxide production (V CO2 ), and energy expenditure were increased in the mINDY À/À mice (Table   S1 ). Because we observed a numerical increase in locomotor activity in the mINDY À/À mice, we also analyzed daytime energy expenditure and locomotor activity separately, which is the time when mice sleep and are typically inactive. During this time, a significant increase in energy expenditure was still observed, without a numerical difference in locomotor activity ( Figures  S4A-S4D ) These data suggest that differences in locomotor activity are likely due to a higher urge of the mINDY À/À mice to ingest their food, as evidenced by the sole increase in locomotor activity during the first 3-4 hr of food ingestion (Figures S4A and S4B) . These data exclude locomotor activity as the main cause of the increase in energy expenditure in the mINDY À/À mice.
Protection from Nutritionally Induced Obesity An increase in energy expenditure might limit weight gain on a HFD. Thus, we studied the effect of 6 weeks of HFD (55% Kcal from fat) on body weight and whole-body fat accumulation. Body weight was reduced by 17% in the mINDY À/À mice compared to mINDY +/+ mice ( Figure 3A) , and the proportion of fat mass to body weight was markedly reduced ( Figure 3B ), while lean body mass was increased in mINDY À/À mice ( Figure 3B ).
Energy expenditure was also increased in the mINDY À/À mice (Table S1 and Figures S4A and S4B ). Basal plasma b-hydroxybutyrate, a marker of hepatic lipid oxidation, was increased by 18% and by 62% in the mINDY +/À mice and the mINDY À/À mice, respectively ( Figure 3C ). To further determine if this effect is specific to liver tissue, we measured hepatic lipid oxidation Figure 3D ). Fittingly, mINDY À/À liver homogenate showed an increase in oxygen consumption by 23% ( Figure 3E Figure 3F ). Together these data show that loss of mIndy reduces hepatic lipid generation from external citrate and induces hepatic lipid oxidation.
Protection from High-Fat Diet Induced Hepatic Steatosis Reduced proportions of fat mass due to increased hepatic lipid oxidation potentially protect from ectopic hepatic lipid accumulation induced by a high-fat diet (HFD). Indeed, liver lipid content was markedly reduced in mINDY À/À HFD-fed mice assessed histologically in liver sections by H&E staining ( Figure 4A , top), oil red O staining ( Figure 4A , middle) and electron microscopy ( Figure 4A , bottom). Hepatic triglyceride content was reduced by 20% in mINDY À/À mice compared to mINDY +/+ mice ( Figure 4B ). We further analyzed hepatic lipid metabolites using LC/MS-MS (Samuel et al., 2004; Erion et al., 2009 ). Long-chain acyl-CoAs did not differ, but hepatic diacylglycerol (DAG) concentrations were reduced by 40% in mINDY À/À mice ( Figure 4D ), without a change in hepatic ceramide content ( Figure 4D ). Hepatic acyl-carnitines tended to be slightly higher in the mINDY À/À mice compared to the mINDY +/+ mice (mINDY À/À mice, 671 ± 34 nmol/g livertissue versus mINDY
, 607 ± 27 nmol/g livertissue, p = 0.1). Ectopic DAG accumulation has been proposed as a unifying hypothesis for mediating the insulin resistance associated with conditions such as high-fat feeding and aging (DAG hypothesis) (Shulman, 2000; Erion and Shulman, 2010; Samuel et al., 2010) . Accordingly, DAG accumulation results from the imbalance between supply and utilization of intracellular lipids. Increased DAG content in turn results in activation of protein kinase Cs (nPKCs) and subsequent impairment in insulin signaling (Shulman, 2000; Samuel et al., 2004 Samuel et al., , 2007 Samuel et al., , 2010 Erion and Shulman, 2010) . In accordance with the DAG hypothesis, mINDY À/À had reduced hepatic membrane PKC3 protein content ( Figure 4C ).
Protection from High-Fat Diet Induced Insulin Resistance
According to the DAG hypothesis, DAG lipid species are major mediators of insulin resistance through activation of nPKCs (Shulman, 2000; Samuel et al., 2004 Samuel et al., , 2007 Samuel et al., , 2010 Erion and Shulman, 2010) . In order to assess the impact of mIndy loss on glucose metabolism in vivo, intraperitoneal glucose tolerance tests (IPGTTs) were performed. Basal plasma glucose and insulin concentrations were decreased in mINDY À/À mice compared to mINDY +/+ mice (Table S2 ). The glycemic excursion during the IPGTT was reduced by 20% (area under the curve), and plasma insulin excursion was reduced by 47% (area under the curve) in mINDY À/À mice compared to mINDY +/+ mice ( Figures 5A and 5B). To discern tissue-specific contributions to improved whole-body insulin sensitivity, hyperinsulinemiceuglycemic (HE) clamps were performed (Figures 5C and 5D and Table S3 [Ayala et al., 2010] ). Consistent with the lower fasting plasma glucose concentrations, basal endogenous glucose production was reduced by 20% in mINDY À/À mice ( Figure 5E ), and endogenous glucose production during the HE clamp was reduced by 50% in the mINDY À/À mice compared to the mINDY +/+ mice ( Figure 5E ), indicating improved hepatic insulin responsiveness. In addition, peripheral glucose uptake (Figure 5F ) by the gastrocnemius muscle ( Figure 5G ) was increased by 38% in the mINDY À/À mice. This protection from fat-induced muscle insulin resistance in mINDY À/À mice was accompanied by a 35% reduction in skeletal muscle DAG content ( Figure 5H ). Reduced transport of citrate into cells could potentially result in lower intracellular citrate concentrations and increased rates of glycolysis (Randle et al., 1963) . In order to test this possibility, we measured plasma lactate concentrations and rates of whole-body glycolysis and nonoxidative glucose metabolism ( Tables S3A-S3C (Tables S3A-S3C ). Taken together, these data demonstrate that increases in whole-body glycolytic flux are not likely responsible for the increased insulinstimulated glucose uptake observed in the mINDY À/À mice.
Deletion of mIndy Increases Mitochondrial Metabolism via AMPK Activation
Citrate infusion studies identified the liver as the main organ of transport action for mINDY. In order to determine the mechanism by which loss of mIndy increases whole-body energy metabolism, we first performed unbiased microarray analysis on hepatic tissue samples from young mINDY +/+ and mINDY À/À mice, without a difference in body composition. Gene set enrichment analysis revealed markedly increased expression of pathways regulating mitochondrial genes, oxidative phosphorylation (OXPHOS), and electron transport chain (ETC) genes in the mINDY À/À mice (Figure 6A) . Consistent with findings in D. melanogaster , mitochondrial density, assessed by the point counting method using electron microscopy (Bergeron et al., 2001) , was increased in mINDY À/À mice ( Figures 6B and 6C ), as were multiple genes related to the ETC, TCA cycle, and OXPHOS (Table S4) . AMP-activated protein kinase (AMPK) is a metabolic regulator that is activated by AMP and inhibited by ATP, which promotes mitochondrial biogenesis, insulin sensitivity, and fat oxidation (Bergeron et al., 2001) . AMPK activity correlates tightly with phosphorylation at Thr172-a subunit (phospho-AMPK).
Fasted mINDY À/À mice exhibit a 52% reduction in hepatic ATP content ( Figure 6D ), a 54% reduction in ATP/ADP ratio (Figure 6D) , and a 62% increase in Thr172 phosphorylation of the a subunit of AMPK ( Figure 6E ). In line with our observation that skeletal muscle citrate uptake did not differ between mINDY
and mINDY À/À mice ( Figure 1D ), ATP content, AMPK activation, and metabolic gene expression profiles did not differ in skeletal muscle samples ( Figures S5A and S5B ). Peroxisome proliferator-activated receptor-g coactivator (PGC)-1a expression, a target of AMPK and a master regulator of mitochondrial biogenesis (Lopez-Lluch et al., 2008), was increased by 64% in liver of the mINDY À/À mice ( Figure 6F ).
Another target of AMPK is acetyl-CoA carboxylase 2 (ACC-2) . ACC-2 serine phosphorylation, which reduces the activity of ACC-2, was also significantly increased in the mINDY À/À mice ( Figure S5C ). Next, we assessed other genes that regulate hepatic lipid oxidation and synthesis and found increased expression in genes that promote fat oxidation in the mINDY À/À mice in liver ( Figure S5D ), but not skeletal muscle ( Figures S5A and S5B ). These data indicate that liver is the main tissue of mIndy action. Protein content of hepatic mature sterol regulatory element binding protein (SREBP)-1c, a lipogenic master regulator, was decreased in mINDY À/À mice ( Figure S5E ). This decrease in mature SREBP1c can also explain the decrease in mitochondrial GPAT (mtGPAT) mRNA expression ( Figure S5D ). In order to assess a causal role of AMPK in mediating changes seen in mINDY Figure S5F ).
Taken together, these data indicate that AMPK activation is at least in part responsible for the observed increases in hepatic fatty acid oxidation and mitochondrial biogenesis as well as for the decrease in hepatic lipogenesis in the mINDY
Protection from Aging-Induced Adiposity and Insulin Resistance Reduced expression of Indy in D. melanogaster and C. elegans increases life span (Rogina et al., 2000; Fei et al., 2004) and reduces specific characteristics of aging in a manner akin to caloric restriction ). Since aging has been shown to be associated with reduced mitochondrial function, ectopic lipid accumulation, and muscle insulin resistance (Petersen et al., 2003) , we examined how loss of mIndy would affect energy and glucose metabolism in older mice. We observed that 8-month-old mINDY À/À mice maintained on a regular chow diet had a 17% reduction in body weight, compared to age-matched littermate mINDY +/+ mice ( Figure 7A ), together with a reduction in fat mass by 45% ( Figure 7B ) and an increase in the proportion of lean body mass by 11% (Figure 7C ). When comparing 3-month-old mINDY À/À to 8-monthold mINDY À/À mice, proportions of fat mass and lean body mass did not change, while in the 8-month-old mINDY +/+ mice, fat mass increased ( Figure 7B ) and lean body mass decreased significantly ( Figure 7B ). Similar to young mice, energy expenditure was increased in the 8-month-old INDY À/À mice compared to 8-month-old INDY +/+ mice (Table S1 ).
Eight-month-old mINDY À/À mice and age-matched mINDY
littermates were subjected to HE clamp studies. Basal glucose and insulin concentrations were reduced by 16% and 29%, respectively, in the older mINDY À/À mice compared to older mINDY +/+ mice (Table S2) . Eight-month-old mINDY À/À mice showed preserved insulin sensitivity compared to 8-month-old mINDY +/+ mice, as reflected by a marked increase in the glucose infusion rate required to maintain euglycemia during the HE clamp ( Figure 7D and Table S3 [Ayala et al., 2010] ). Endogenous glucose production ( Figure 7E , Table S3 ) during the HE clamp was 2-fold lower in older mINDY À/À mice compared to older (D) Glucose infusion rate during HE clamp studies is increased with deletion of mIndy (n = 6-9). (E) Endogenous glucose production in the basal and the clamped state (n = 6-9). (F) Peripheral glucose uptake during the HE clamp studies (n = 6-9). (G) 14 C-2-deoxyglucose uptake into gastrocnemius muscle during the HE clamp is increased with deletion of mIndy (n = 5). (H) Gastrocnemius muscle DAG content assessed by LC/MS/MS is reduced in mINDY À/À mice (n = 5). *p < 0.05, # p < 0.01 by two-way ANOVA, all error bars represent SEM, also see Table S3 .
Cell Metabolism mINDY and Mammalian Metabolism mINDY +/+ mice, reflecting increased hepatic insulin responsiveness in the mINDY À/À mice ( Figure 7F ). Whole-body glucose metabolism during the HE clamp was increased by 68% in the 8-month-old mINDY À/À mice ( Figure 7G ), which could be attributed to a 27% increase in skeletal muscle glucose transport activity ( Figure 7H ) and a 43% increase in hepatic nonoxidative glucose metabolism (Table S3) .
Deletion of mIndy Mimics Various Transcriptional Aspects of Calorie Restriction
Decreased Indy expression has been proposed to mimic a state of caloric restriction in D. melanogaster Neretti et al., 2009 (E) Representative immunoblots of hepatic AMP-activated protein kinase (AMPK) a Thr172 phosphorylation/total AMPK content (n = 6).
(F) Representative immunoblots of hepatic PGC-1a expression (n = 6), all error bars represent SEM, see also Figure S5 .
compared them to the regulation of pathways in calorically restricted mice versus ad libitum-fed mice. Eighty percent of pathways were regulated in a similar fashion in mINDY À/À and calorically restricted mice ( Figure S6A ). Furthermore, calorie restriction has been shown to reduce Indy mRNA expression in D. melanogaster. We investigated whether similar results would be observed after a prolonged fast in mice. Consistent with these results, mIndy expression was reduced by 48% in mice starved for 36 hr compared to fed mice ( Figure S6B ). In order to assess the physiological impact of starvation on mINDY À/À mice, we compared mINDY +/+ and mINDY À/À animals that were fasted for 24 hr and 48 hr hours. mINDY À/À mice showed greater weight loss and markedly reduced glycogen stores after 24 hr ( Figures S7A and 7B ), while plasma glucose and insulin concentrations tended to be lower after 24 hr ( Figures  S7C and S7D ). 
DISCUSSION
Reduced expression of Indy and its homologs increases life span in D. melanogaster and C. elegans (Rogina et al., 2000; Fei et al., 2004) . These findings have been compared to caloric restriction , an intervention that extends life span in diverse species including mammals (Colman et al., 2009; Fontana and Klein, 2007) . Here, we show that deletion of the mIndy homolog in mice reduces adiposity, prevents lipid accumulation into liver and skeletal muscle, and increases insulin sensitivity under HFD conditions and during aging. Loss of mIndy augments energy expenditure associated with increased hepatic fat oxidation and attenuates hepatic lipogenesis. Strikingly, caloric intake is not decreased in mINDY À/À mice.
Consistent with previous studies (Knauf et al., 2002 (Knauf et al., , 2006 , we show that mINDY is a high-capacity plasma membrane transporter for citrate (K m 49 ± 9 mM). Cytosolic citrate either originates from mitochondria, where it is generated in one turn of the citric acid cycle for the ultimate conversion into ATP, or citrate is taken up across the plasma membrane from the blood stream, in which it circulates in relatively high concentrations ($50-150 mM) (Palmieri, 2004) . Citrate is cleaved to oxaloacetate and acetyl-CoA, which provides the immediate carbon source for the biosynthesis of fatty acids, triacylglycerols, and cholesterol (Muoio and Newgard, 2008) . Fatty acids provide >70% of the energy requirements of the liver (Alves et al., 2011) . We show that loss of mIndy reduces hepatocellular fatty acid and sterol generation and promotes hepatic lipid oxidation and thus reduces ectopic storage of fat in the liver. In line with this, enhancing the function of the human mIndy gene product dose-dependently increases the cellular uptake of [ 14 C]-citrate as well as its incorporation into intracellular lipids .
Deletion of mIndy induces a state of hepatic energy depletion, as reflected by the decrease in hepatic ATP content and ATP/ ADP ratio. Increased AMP and decreased ATP concentrations are major activators of AMPK . Our data suggest that reduced uptake of mINDY substrates leads to depletion of biochemical energy, which results in the activation of AMPK. Recent studies have shown that intracerebroventricular injection of citrate inhibits hypothalamic AMPK, which is consistent with this possibility (Stoppa et al., 2008) . AMPK induces hepatic fatty acid oxidation through phosphorylation and inhibition of ACC-2 activity, reduces lipid generation by inhibition of SREBP-1c (Kahn et al., 2005) , and promotes the generation of ATP by inducing mitochondrial biogenesis through activation of PGC-1a (Bergeron et al., 2001; Zhang et al., 2009 ). The mIndy-deleted phenotype is consistent with these traits.
Moreover, cytosolic citrate acts as a turnstile in fuel sensing and signaling, by allosteric activation of ACC-2 Ruderman et al., 1999) , and it might inhibit glycolysis in the presence of ATP (Bosca et al., 1985) . Together, these data indicate that citrate also acts as a signaling molecule and consequently that reduced citrate signaling activity might contribute to the mIndy-deleted phenotype. Yet our data do not completely rule out the possibility that mINDY also exerts effects independent of the uptake mechanism.
mIndy expression and activity are most abundant in liver and much lower in other organs and tissues, but loss of mIndy not only affected hepatic metabolism but also increased energy expenditure, which in turn reduced whole-body fat content as well as skeletal muscle lipid storage, and it increased insulinstimulated glucose uptake into skeletal muscle. These results show similarities to liver-specific overexpression of AMPK (Yang et al., 2008) in HFD-fed mice and other mouse models with specifically targeted tissues and organs (Oyadomari et al., 2008; Ahmadian et al., 2009; Dean et al., 2009) . It is likely that the relatively minor phenotype observed in the young mINDY À/À mice can also be attributed to the compensatory increase in expression of SLC13A3 (NaDC3). With high-fat feeding, the compensatory increase in SLC13A3 is abolished, and the metabolic phenotype is fully developed.
Energy expenditure increases in response to water ingestion through sympathetic nervous system activation (Boschmann et al., 2007; Lechner et al., 2011) . It is therefore possible that augmented water drinking, as observed in the HFD-fed and older mINDY À/À mice, could have contributed to the observed increase in energy expenditure. However, this event would not explain the increase in energy expenditure in the young, regular chow-fed mINDY À/À mice that have a normal drinking pattern.
Caloric restriction promotes mitochondrial biogenesis and function Lopez-Lluch et al., 2008) . Caloric restriction is effective in correcting the unfavorable metabolic consequences of high-fat feeding and aging (Fontana and Klein, 2007) . We show that in calorically restricted mice, as compared to isocalorically fed mice, 80% of transcriptionally regulated pathways change in the same direction as in the mINDY À/À mice. Functionally, loss of mIndy also mimics many aspects of caloric restriction. Moreover, in flies and nematodes, both, reduced expression of Indy and caloric restriction prolong life span (Rogina et al., 2000; Fei et al., 2004) , and AMPK has been shown to be the mediator of longevity in response to most dietary restriction regimens in C. elegans (Schulz et al., 2007; Greer and Brunet, 2009; Mair et al., 2011) . In addition, caloric restriction does not increase life span further in flies with reduced Indy expression (Toivonen et al., 2007; Wang et al., 2009 ), pointing to similar underlying mechanisms in both conditions. These data suggest that mIndy may be a key mediator of the beneficial effects of dietary energy restriction. Since prolonged caloric restriction is very difficult to achieve in humans, our observations raise the tantalizing possibility that modulating the levels or function of mIndy could lead to some of the health-promoting effects of calorie restriction, without requiring severe caloric restriction.
Hepatic lipid content is strongly associated with hepatic insulin resistance . A unifying hypothesis is that insulin resistance in liver and skeletal muscle develops when there is an imbalance between supply and utilization of intracellular lipid, leading to net accumulation of intracellular diacylglycerol (DAG hypothesis) (Shulman, 2000; Erion and Shulman, 2010) . In contrast, with aging, declines in mitochondrial function may contribute to net accumulation of intracellular DAGs (Petersen et al., 2003; Reznick et al., 2007; Lee et al., 2010) . Consistent with this hypothesis, loss of mIndy reduces hepatic DAG concentrations, decreases membrane PKC3 content, and protects from hepatic insulin resistance associated with high-fat feeding and aging.
In summary, we show that the deletion of the mammalian homolog of Drosophila Indy, protects mice from HFD-induced and age-associated insulin resistance, which is at least in part mediated by activation of AMPK with subsequent induction of mitochondrial biogenesis via PGC-1a, increased hepatic lipid oxidation, and energy expenditure, as well as reduced hepatic lipid generation. Our data suggest that mIndy may be an attractive therapeutic target for the treatment of nonalcoholic fatty liver disease, obesity, and type 2 diabetes.
EXPERIMENTAL PROCEDURES

Generation of Mice
A detailed description is given in the Supplemental Experimental Procedures.
Cloning of Mouse mINDY and Uptake Assays
Uptake assays were performed as described (Seithel et al., 2007) . Briefly, the cDNA encoding mouse mINDY was cloned using a PCR-based approach. HEK293 cells were transfected with pIndy-mouse.3.1 using Effectene transfection reagent (QIAGEN, Hilden, Germany). Uptake assays were performed using HEK-mIndy cells, and HEK-Co/418 cells transfected with the empty expression vector pcDNA3.1(+) serving as control cells. [1,5- 14 C]citric acid and [1,4-14 C]succinate (Hartmann Analytic, Germany) were dissolved in uptake buffer, and unlabeled citric acid or succinate was added to the final concentration mentioned. The cells were incubated with the uptake solution for 10 min as described (Seithel et al., 2007 Infusion Studies HE clamp studies were conducted as described Pajvani et al., 2011) . Details are given in the Supplemental Experimental Procedures.
Biochemical Analysis and Calculations
Calculations were done as described (Chutkow et al., 2010; Jornayvaz et al., 2011) , and details are given in the Supplemental Experimental Procedures.
mRNA Quantification by Real-Time PCR Liver total RNA was isolated using the RNeasy kit per manufacturer's instructions (Invitrogen Corporation, CA, USA), and qPCR was performed as described . Primer sequences are displayed in Table S5 .
Immunoblots Immunoblots were performed as described . Phospho-AMPK and AMPK (Cell Signaling Technology, MA, USA), phospho-ACC2 and ACC2 (Santa Cruz Biotechnology Inc., CA, USA), PGC-1a (Cell Signaling Technology, MA, USA), SREBP-1c (Santa Cruz Biotechnology Inc., CA, USA), b-actin (Abcam, MA, USA), and Gapdh (Cell Signaling Technology, MA, USA) were used as primary antibodies. PKC3 assays were performed as described (Samuel et al., 2004) .
Transmission Electron Microscopy Analysis
Individual liver samples were prepared as described (Bergeron et al., 2001) . Only cross-sections of liver were examined for quantification of mitochondrial density. For each individual liver slice, six random pictures were taken at a magnification of 7,1003 and printed at a final magnification of 18,2503. The volume density of mitochondria was estimated using the point-counting method (Bergeron et al., 2001 ) by a sample-blinded EM technician. The average volume density was calculated for each individual mouse liver and was used to calculate the average volume density for each genotype.
Lipid Oxidation and Lipid Synthesis in Primary Hepatocytes
Details are given in the Supplemental Experimental Procedures. Briefly, primary hepatocytes were isolated at the Yale Liver Center. 10 6 cells per flask were incubated in Williams E Medium with 0.1 mM [1-14 C]oleate (Amersham Biosciences, NJ, USA). After 1 hr, incubations were quenched with 20% perchloric acid, and hyamine hydroxide was added to the filter paper in the center well to collect [ 14 CO 2 ]. After 1 hr on ice, filter paper and perchloric acid-soluble 14 C-radioactivity were counted in a scintillation counter (New et al., 1999) . Reactions were normalized to protein amounts. Lipid synthesis was assessed in cultures of isolated hepatocytes (10 6 ) with William E medium, 10 nM insulin, and 10 mM [1,5-14 C]-citric acid (Movarek Biochemicals, CA, USA) for 24 hr. Cells were homogenized in PBS and mixed with 10N NaOH and ethanol. Sterols were extracted with hexanes twice. The lower layer, containing sterols, was first mixed with 10M H 2 SO 4 and then extracted with hexanes. The upper layer was then dried and counted in a scintillation counter to determine [ 14 C]-fatty acids.
Oxygen Consumption in Liver Homogenate
Oxygen consumption was assessed with a Clark-type oxygen electrode (Hansatech Instruments, UK) as described with the exception that liver homogenate was used.
Plasma Metabolite Extraction, Measurement, Alignment, and Normalization Murine plasma (30ml) was extracted with 400 ml 100% methanol at À20 C ( 13 C-sorbitol was added as an internal standard). After centrifugation, the supernatant was vacuum dried. GC-TOF-MS metabolite profiling was performed on a Leco Pegasus 3 time-of-flight mass spectrometer (Leco, St. Joseph, MI, USA). The Direct Thermal Desorption injector (ATAS GL International, The Netherlands) was coupled to an HP 5890 gas chromatograph and an autosampler with automatic derivatisation and linear exchange. This eliminates the impact of potential degradation or synthesis artifacts and sample carryover. During the derivatisation there was also added a retention time index standard mixture. For detailed information, refer to Lisec et al. (2006) and Catchpole et al. (2011) . Chromatogram acquisition parameters were those described previously (Weckwerth et al., 2004) . The results were exported from Leco Chroma TOF software (version 3.25) as cdf files. Peak detection, retention time alignment, and library matching were performed with the R-script ''Target Search'' (Cuadros-Inostroza et al., 2009). Relative peak intensities were normalized by the median of 13 C-sorbitol intensities of all samples by the 13 C-sorbitol intensity of the respective sample and log 10 transformed.
ATP and ADP Content
Liver extracts were prepared for high field NMR analysis by homogenizing 100 mg of tissue in 0.9% perchloric acid (2 v/w) and ethanol (2v/w). After homogenization, samples were centrifuged, and the supernatant was extracted and neutralized with K 2 CO 3 , lyophilized, and resuspended in buffer containing 20 mM HEPES (pH 6), 20 mM EDTA, 0.5 M KCl, 50% D 2 O, and 1 mM phenylphosphonic acid (Sigma-Aldrich, St. Louis, MO). ATP and ADP content was analyzed using a Bruker 5 mm 31 P-NMR probe in an 11.7-T vertical magnet. Spectra were acquired with TR = 1 s, NS = 2048, and 32K data.
Microarray Analysis
Microarray data were analyzed using DIANE 6.0, a spreadsheet-based microarray analysis program based on SAS JMP7.0 system. All raw data are available in the GEO database. Details are given in the Supplemental Experimental Procedures.
Statistical Analysis
A two-tailed Student's t test was used to test differences between mINDY +/+ and mINDY À/À mice. One-way ANOVA analysis was performed for multiple comparisons, and two-way ANOVA was performed to test multiple timedependent effects. Values are presented as mean ± SEM; p < 0.05 was considered statistically significant.
ACCESSION NUMBERS
Raw data were subjected to Z normalization and deposited in the Gene Expression Omnibus (GEO) repository (accession number GSE29984 for mINDY +/+ versus mINDY À/À and GSE11845 for the CR mINDY +/+ ). 
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